⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2026American Journal of Cancer Research

STAC3 as a poor prognostic biomarker in renal clear cell carcinoma: relationship with immune infiltration: Am J Cancer Res. 2024; 14(7): 3294-3316

View at Publisher

Ask AI

Bookmark

Share

Key Points

STAC3 serves as a poor prognostic biomarker for renal clear cell carcinoma, affecting patient outcomes.
Higher levels of immune infiltration correlate with poor prognostic indications linked to STAC3 expression.
This observational analysis assessed the relationship of STAC3 with immune infiltration in renal clear cell carcinoma cases.
These findings suggest that STAC3 may influence treatment strategies, though further validation is warranted.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Analysis reveals STAC3's role as a poor prognostic biomarker in renal clear cell carcinoma, indicating immune infiltration links.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yingnan Zhang (2026) studied this question.

synapsesocial.com/papers/69a76567badf0bb9e87d8fce https://doi.org/10.62347/brvv2647

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Risk factors for cardiac dysfunction caused by anthracycline drugs in the treatment of lymphoma and the early monitoring value of three-dimensional echocardiographyAmerican Journal of Cancer Research · Thu,
2Increasing autophagy activity suppresses Helicobacter pylori infection-related gastric cancer tumorigenesis both in vitro and in vivoAmerican Journal of Cancer Research · Thu,
3Angiopoietin-like 4 deficiency upregulates macrophage function through the dysregulation of cell-intrinsic fatty acid metabolism [Retraction]American Journal of Cancer Research · Thu,
4KLF5 mediates the hyper-proliferative phenotype of the intestinal epithelium in mice with intestine-specific endogenous K-RasG12D expression: Am J Cancer Res. 2018; 8(4): 723-731American Journal of Cancer Research · Thu,
5Immune checkpoint inhibitors combined with chemotherapy enhance coagulation activation and elevate venous thromboembolism risk in non-small cell lung cancerAmerican Journal of Cancer Research · Thu,

More from American Journal of Cancer Research

The efficacy and mechanism of thoracic photodynamic therapy mediated by hematoporphyrin injection on disseminated pleural malignancies of Lewis lung carcinoma in mice: Am J Cancer Res. 2022; 12(4): 1502-1510Thu,
Metachronous triple primary malignancies of duodenum, skin, and appendix in the absence of common hereditary syndromes: a case reportThu,
Restoring osimertinib sensitivity in EGFR-mutant NSCLC: the role of anlotinib in modulating Wnt/β-catenin/YAP pathwaysThu,
Second-line nab-paclitaxel and gemcitabine for advanced pancreatic cancer following FOLFIRINOX: outcomes and insightsThu,
SOX8 mediates the crosstalk between KRAS and TGF-β pathways to promote the malignant progression of pancreatic cancerThu,